Lilly Icos: A Complementary Alliance

The Lilly Icos joint venture for the erectile dysfunction drug Cialis has the markings of a complementary alliance. Though too soon to gauge its commercial efficacy, so far the deal is working because both parties view it as a vehicle to build value of the sort important to them.

By Deborah Erickson

It's a real, if generally unspoken, fact of business life: pharmaceutical product deals always have an inherent tension that stems...

More from Leadership

More from In Vivo